Friday, October 11, 2019 1:32:11 PM
Scotty, there is a lot of possible ground between unblind and shut the doors! First of all as a long I do hope that we WILL SOON be unblinding finally and hopefully have positive results and maybe even become the new SOC. But even if not, NWBO is astride one of the major avenues toward using the immune system to battle cancer and even other disease. They have valuable patents and know how and all sorts of possibilities with Direct and combos etc and a better specified trial for GBM should this one not prove to be SS. financially you may have a point, I am sure no one is happy with a 24 cent share price. But that could prove to turn with just one good PR that we are all waiting for.
I have some issues with possible self dealing as apparently does the SEC which still sees this as a problem area not yet remediated. Among several posts from years ago about possible self dealing to my recent post about possible self dealing in the D1 and D2 warrants issued to retail investors, but to LP on much more favorable terms. I would hope those terms get equalized in the final clean up demanded by the SEC in this area of management. As I have stated in old posts, I am willing to lay low and rock the boat at this time but I suspect that if NWBO proves successful and becomes a valuable property, that these issues will be worth litigating at that time by any who still feel cheated by any self dealing.
I have some issues with possible self dealing as apparently does the SEC which still sees this as a problem area not yet remediated. Among several posts from years ago about possible self dealing to my recent post about possible self dealing in the D1 and D2 warrants issued to retail investors, but to LP on much more favorable terms. I would hope those terms get equalized in the final clean up demanded by the SEC in this area of management. As I have stated in old posts, I am willing to lay low and rock the boat at this time but I suspect that if NWBO proves successful and becomes a valuable property, that these issues will be worth litigating at that time by any who still feel cheated by any self dealing.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
